Natural Antibodies and Alloreactive T Cells Long after Kidney Transplantation.

Background: The relationship between circulating effector memory T and B cells long after transplantation and their susceptibility to immunosuppression are unknown. To investigate the impact of antirejection therapy on T cell-B cell coordinated immune responses, we assessed IFN--producing memory cells and natural antibodies (nAbs) that potentially bind to autoantigens on the graft.

Methods: Plasma levels of IgG nAbs to malondialdehyde (MDA) were measured in 145 kidney transplant recipients at 5-7 years after transplantation. In 54 of these patients, the number of donor-reactive IFN--producing cells was determined. 35/145 patients experienced rejection, 18 of which occurred within 1 year after transplantation.

Results: The number of donor-reactive IFN--producing cells and the levels of nAbs were comparable between rejectors and nonrejectors. The nAbs levels were positively correlated with the number of donor-reactive IFN--producing cells (  = 0.39, =0.004). The positive correlation was only observed in rejectors (  = 0.53, =0.003; nonrejectors:  = 0.24, =0.23). Moreover, we observed that intravenous immune globulin treatment affected the level of nAbs and this effect was found in patients who experienced a late ca-ABMR compared to nonrejectors (=0.008).

Conclusion: The positive correlation found between alloreactive T cells and nAbs in rejectors suggests an intricate role for both components of the immune response in the rejection process. Treatment with intravenous immune globulin impacted nAbs.